Management of Gross Hematuria
Gross hematuria requires prompt and thorough evaluation as it carries a >10% risk of malignancy and should always trigger immediate urologic referral for complete investigation. 1, 2
Initial Evaluation
Risk Stratification:
- High-risk factors include:
- Age (women ≥50 years, men ≥40 years)
- Smoking history >30 pack-years
- History of pelvic radiation
- Chronic urinary infections
- Occupational exposures to dyes or chemicals 1
- High-risk factors include:
Laboratory Assessment:
Diagnostic Imaging
- First-line imaging: CT urography (92% sensitivity, 93% specificity) 1
- Alternative imaging (for patients with renal insufficiency or contrast allergy):
- MR urography
- Renal ultrasound (50% sensitivity, 95% specificity) 1
Specialist Referral
- Immediate urology referral for cystoscopy in all cases of gross hematuria 1, 2
- Nephrology referral if:
- Significant proteinuria (>1g/day)
- Evidence of glomerular disease
- Renal insufficiency 1
Specific Management Based on Etiology
Urinary Tract Infection:
- Appropriate antibiotic therapy based on culture results 1
Urolithiasis:
- Pain management
- Hydration
- Urologic intervention for obstructing stones 1
Benign Prostatic Hyperplasia:
- Medical therapy or surgical intervention as indicated 1
Malignancy:
- Prompt referral for definitive management
- Delays >9 months in evaluation are associated with decreased survival in bladder cancer 1
Anticoagulant-Associated Bleeding:
- Full urologic evaluation is still warranted even with excessive anticoagulation
- Tumors were found in 18% of patients with excessive anticoagulation 3
Follow-up and Monitoring
- Repeat urinalysis within 2 weeks to assess persistence 1
- Close monitoring of renal function and electrolytes 1
- Immediate reevaluation if:
- Recurrence of gross hematuria
- Significant increase in microscopic hematuria
- Development of new urological symptoms 1
Common Pitfalls to Avoid
- Assuming a benign cause without complete evaluation, especially in high-risk patients 1
- Using inadequate imaging (e.g., ultrasound alone) in high-risk patients 1
- Dismissing hematuria in patients with overactive bladder symptoms 1
- Sex-based disparities in referral patterns 1
- Delaying evaluation (>9 months) which can decrease survival in patients with bladder cancer 1
- Deferring investigation due to anticoagulant use - even patients with excessive anticoagulation require full evaluation 3
Remember that gross hematuria represents a serious finding that warrants immediate and thorough investigation. The physician who delays or defers careful investigation does the patient a disservice and may inadvertently permit a significant disease process to become more extensive 4.